- Release Date: 21/08/23 09:13
- Summary: Approval of Clinical Trial of CYP-001 in Kidney Transplant
- Price Sensitive: Yes
- Download Document 226.05KB
- Forums
- ASX - By Stock
- Ann: Approval of Clinical Trial of CYP-001 in Kidney Transplant
CYP
cynata therapeutics limited
Add to My Watchlist
2.63%
!
19.5¢

Ann: Approval of Clinical Trial of CYP-001 in Kidney Transplant
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $46.30M |
Open | High | Low | Value | Volume |
19.0¢ | 19.5¢ | 19.0¢ | $4.468K | 23.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 58425 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 280820 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 58425 | 0.190 |
1 | 50000 | 0.185 |
4 | 117115 | 0.180 |
4 | 135266 | 0.175 |
3 | 155886 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 280820 | 6 |
0.205 | 184639 | 1 |
0.210 | 58702 | 3 |
0.215 | 10000 | 1 |
0.220 | 3996 | 2 |
Last trade - 13.43pm 15/09/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, MD & CEO
Nick Rathjen
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online